Total Payments
$3,062
2024 Payments
$2,409
Companies
14
Transactions
120
Payment Breakdown by Category
Food & Beverage$3,062 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,062 | 120 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $597.90 | 27 | $0 (2024) |
| ABBVIE INC. | $533.35 | 19 | $0 (2024) |
| Madrigal Pharmaceuticals | $397.95 | 10 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $377.42 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $272.32 | 22 | $0 (2024) |
| Lilly USA, LLC | $219.69 | 10 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $189.13 | 5 | $0 (2024) |
| FUJIFILM Healthcare Americas Corporation | $121.36 | 1 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $119.27 | 4 | $0 (2024) |
| Genentech USA, Inc. | $108.47 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,409 | 97 | ABBVIE INC. ($533.35) |
| 2023 | $629.55 | 22 | Gilead Sciences, Inc. ($222.71) |
| 2021 | $23.73 | 1 | Hologic, LLC ($23.73) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: VIROLOGY | ||||||
| 12/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.17 | General |
| 12/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.38 | General |
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Mirum Pharmaceuticals, Inc. | Livmarli (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Alagille syndrome | ||||||
| 11/21/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Rare Disease | ||||||
| 11/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $134.92 | General |
| Category: LIVER DISEASE | ||||||
| 11/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $54.08 | General |
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.41 | General |
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.45 | General |
| 11/06/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: VIROLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: VIROLOGY | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.88 | General |
| 10/23/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $137.61 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: LIVER DISEASE | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: LIVER DISEASE | ||||||
| 10/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: VIROLOGY | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Obesity | ||||||
| 10/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: VIROLOGY | ||||||
About Melissa Real
Melissa Real is a Physician Assistant healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2020. The National Provider Identifier (NPI) number assigned to this provider is 1326675414.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Real has received a total of $3,062 in payments from pharmaceutical and medical device companies, with $2,409 received in 2024. These payments were reported across 120 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($3,062).
Ad
Practice Information
- Specialty Physician Assistant
- Location Pasadena, CA
- Active Since 03/26/2020
- Last Updated 03/26/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1326675414
Products in Payments
- MAVYRET (Drug) $533.35
- XIFAXAN (Drug) $272.32
- RESMETIROM (Drug) $260.34
- Bylvay (Drug) $195.48
- OCALIVA (Drug) $189.13
- IQIRVO (Drug) $181.94
- REZDIFFRA (Drug) $137.61
- UTASWAKO AFP-L3 (Device) $121.36
- Vemlidy (Drug) $120.99
- ZEPBOUND (Drug) $120.26
- TERLIVAZ (Drug) $119.27
- Tecentriq (Biological) $108.47
- MOUNJARO (Drug) $50.96
- Livmarli (Drug) $44.12
- TheraSphere Y90 Glass Microspheres 10 GBq (Device) $42.52
- APTIMA (Device) $23.73
- Wegovy (Drug) $14.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Pasadena
Nour Shahab, Pa-C, PA-C
Physician Assistant — Payments: $14,099
Physician Assistant $14,099
Thuy Hua, Pa-C, PA-C
Physician Assistant — Payments: $10,130
Physician Assistant $10,130
Mrs. Iman Jomaa
Physician Assistant — Payments: $7,726
Physician Assistant $7,726
Julia Berman
Physician Assistant — Payments: $5,989
Physician Assistant $5,989
Ms. Jessica Hanson, Pa-C, PA-C
Physician Assistant — Payments: $4,951
Physician Assistant $4,951
Carlitos Chen
Physician Assistant — Payments: $4,613
Physician Assistant $4,613